All Stories

  1. Targeting glucose metabolism with dichloroacetate (DCA) reduces zika virus replication in brain cortical progenitors at different stages of maturation

    Article • Antiviral Research, August 2024, Elsevier

    Professor William s James

  2. Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2

    Article • Open Biology, June 2024, Royal Society Publishing

    Dr John Douglas Clarke, Professor William s James

  3. Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses

    Article • Nature Nanotechnology, May 2024, Springer Science + Business Media

    Professor William s James

  4. Hypoxia dampens innate immune signalling at early time points and increases Zika virus RNA levels in iPSC-derived macrophages

    Article • Journal of General Virology, August 2023, Society for General Microbiology

    Professor William s James

  5. Zika virus-induces metabolic alterations in fetal neuronal progenitors that could influence in neurodevelopment during early pregnancy

    Article • Biology Open, April 2023, The Company of Biologists

    Professor Zoltan Molnar, Professor William s James

  6. Density dependent regulation of inflammatory responses in macrophages

    Article • Frontiers in Immunology, December 2022, Frontiers

    Professor William s James

  7. Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice

    Article • Journal of Immunological Methods, December 2022, Elsevier

    Professor William s James

  8. Single-cell transcriptomics defines an improved, validated monoculture protocol for differentiation of human iPSC to microglia

    Article • Scientific Reports, November 2022, Springer Science + Business Media

    Professor William s James

  9. Type I interferon receptor (IFNAR2) deficiency reveals Zika virus cytopathicity in human macrophages and microglia

    Article • Frontiers in Immunology, November 2022, Frontiers

    Professor William s James

  10. Radical-SAM dependent nucleotide dehydratase (SAND), rectification of the names of an ancient iron-sulfur enzyme using NC-IUBMB recommendations

    Article • Frontiers in Molecular Biosciences, October 2022, Frontiers

    Professor William s James

  11. Aberrant inflammatory responses to type I interferon in STAT2 or IRF9 deficiency

    Article • Journal of Allergy and Clinical Immunology, October 2022, Elsevier

    Professor William s James

  12. SAMHD1 controls nucleoside-based cancer therapeutics, deoxyguanosine toxicity, and inflammation

    Article • August 2022, Cold Spring Harbor Laboratory Press

    Professor William s James

  13. Zika virus-induces metabolic alterations in fetal neuronal progenitors that could influence in neurodevelopment during early pregnancy

    Article • August 2022, Cold Spring Harbor Laboratory Press

    Professor Zoltan Molnar, Professor William s James

  14. Human iPSC co-culture model to investigate the interaction between microglia and motor neurons

    Article • Scientific Reports, July 2022, Springer Science + Business Media

    Professor William s James

  15. Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses

    Article • PLoS Neglected Tropical Diseases, April 2022, PLOS

    Vinod Balasubramaniam , Professor William s James

  16. A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern

    Article • Communications Medicine, April 2022, Springer Science + Business Media

    Professor William s James

  17. Zika Virus Neuropathogenesis: The Different Brain Cells, Host Factors and Mechanisms Involved

    Article • Frontiers in Immunology, March 2022, Frontiers

    Professor William s James

  18. Divergent trajectories of antiviral memory after SARS-CoV-2 infection

    Article • Nature Communications, March 2022, Springer Science + Business Media

    Mark Philip Cassar, Professor William s James

  19. Host Molecules Regulating Neural Invasion of Zika Virus and Drug Repurposing Strategy

    Article • Frontiers in Microbiology, March 2022, Frontiers

    Professor William s James

  20. Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences

    Article • eLife, January 2022, eLife

    Professor William s James

  21. SARS-CoV-2 Variants, Vaccines, and Host Immunity

    Article • Frontiers in Immunology, January 2022, Frontiers

    Professor William s James

  22. T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

    Article • The Lancet Microbe, January 2022, Elsevier

    Professor William s James

  23. Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

    Article • Theranostics, January 2022, Ivyspring International Publisher

    Professor William s James

  24. An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

    Article • Nature Immunology, December 2021, Springer Science + Business Media

    Professor William s James

  25. Neutralizing Antibodies to SARS‐CoV‐2 Selected from a Human Antibody Library Constructed Decades Ago

    Article • Advanced Science, October 2021, Wiley

    Professor William s James

  26. Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response

    Article • Frontiers in Immunology, October 2021, Frontiers

    Professor William s James

  27. A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19

    Article • Nature Communications, September 2021, Springer Science + Business Media

    Professor William s James

  28. The use of nanobodies in a sensitive ELISA test for SARS-CoV-2 Spike 1 protein

    Article • Royal Society Open Science, September 2021, Royal Society Publishing

    Professor William s James

  29. Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern

    Article • Nature Communications, August 2021, Springer Science + Business Media

    Mark Philip Cassar, Professor William s James

  30. Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress

    Article • Nature Communications, July 2021, Springer Science + Business Media

    Professor William s James

  31. A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19

    Article • July 2021, Springer Science + Business Media

    Professor William s James

  32. Differentiation of human induced pluripotent stem cells to authentic macrophages using a defined, serum-free, open-source medium

    Article • Stem Cell Reports, July 2021, Elsevier

    Professor William s James

  33. Absolute quantitation of individual SARS-CoV-2 RNA molecules: a new paradigm for infection dynamics and variant differences

    Article • June 2021, Cold Spring Harbor Laboratory Press

    Professor William s James

  34. Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

    Article • Cell, April 2021, Elsevier

    Professor William s James

  35. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells

    Article • Cell Reports, April 2021, Elsevier

    Professor William s James

  36. Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

    Article • Cell, April 2021, Elsevier

    Professor William s James

  37. Naturally-acquired immunity in Syrian Golden Hamsters provides protection from re-exposure to emerging heterosubtypic SARS-CoV-2 variants B.1.1.7 and B.1.351

    Article • March 2021, Cold Spring Harbor Laboratory Press

    Professor William s James

  38. Breadth and function of antibody response to acute SARS-CoV-2 infection in humans

    Article • PLoS Pathogens, February 2021, PLOS

    Professor William s James

  39. In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages

    Article • Journal of Visualized Experiments, February 2021, MyJove Corporation

    Professor William s James

  40. Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

    Article • Nature Structural & Molecular Biology, February 2021, Springer Science + Business Media

    Professor William s James

  41. The antigenic anatomy of SARS-CoV-2 receptor binding domain

    Article • Cell, February 2021, Elsevier

    Professor Nigel James Temperton, Professor William s James

  42. Tissue-resident macrophages regulate lymphatic vessel growth and patterning in the developing heart

    Article • Development, February 2021, The Company of Biologists

    Professor William s James

  43. T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study

    Article • SSRN Electronic Journal, January 2021, Elsevier

    Professor William s James

  44. Honing the Double-Edged Sword: Improving Human iPSC-Microglia Models

    Article • Frontiers in Immunology, December 2020, Frontiers

    Professor William s James

  45. Interferon‐stimulated gene products as regulators of central carbon metabolism

    Article • European Journal of Biochemistry, December 2020, Wiley

    Professor William s James

  46. TREM2 Alzheimer’s variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages

    Article • Alzheimer s Research & Therapy, November 2020, Springer Science + Business Media

    Professor William s James

  47. Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

    Article • Nature Structural & Molecular Biology, October 2020, Springer Science + Business Media

    Professor William s James

  48. SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus

    Article • Wellcome Open Research, October 2020, Faculty of 1000, Ltd.

    Professor William s James

  49. Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication

    Article • Scientific Reports, August 2020, Springer Science + Business Media

    Professor William s James

  50. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

    Article • The Lancet, August 2020, Elsevier

    Professor William s James

  51. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

    Article • Nature Structural & Molecular Biology, July 2020, Springer Science + Business Media

    Professor William s James

  52. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

    Article • Nature Structural & Molecular Biology, July 2020, Springer Science + Business Media

    Professor William s James

  53. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Professor William s James

  54. SARS-CoV-2 RNA detected in blood samples from patients with COVID-19 is not associated with infectious virus

    Article • May 2020, Cold Spring Harbor Laboratory Press

    Professor William s James

  55. LRRK2 Is Recruited to Phagosomes and Co-recruits RAB8 and RAB10 in Human Pluripotent Stem Cell-Derived Macrophages

    Article • Stem Cell Reports, May 2020, Elsevier

    Professor William s James

  56. ddhCTP produced by the radical‐SAM activity of RSAD2 (viperin) inhibits the NAD+‐dependent activity of enzymes to modulate metabolism

    Article • FEBS Letters, April 2020, Wiley

    Professor William s James

  57. Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication

    Article • April 2020, Cold Spring Harbor Laboratory Press

    Professor William s James

  58. Viperin, through its radical‐SAM activity, depletes cellular nucleotide pools and interferes with mitochondrial metabolism to inhibit viral replication

    Article • FEBS Letters, March 2020, Wiley

    Professor William s James

  59. Mechanism of Diol Dehydration by a Promiscuous Radical‐SAM Enzyme Homologue of the Antiviral Enzyme Viperin (RSAD2)

    Article • ChemBioChem, February 2020, Wiley

    Professor William s James

  60. A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy

    Article • mAbs, January 2020, Taylor & Francis

    Professor William s James

  61. Hypoxic and Pharmacological Activation of HIF Inhibits SARS-CoV-2 Infection of Lung Epithelial Cells

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Professor William s James

  62. SARS-CoV-2 Assembly and Egress Pathway Revealed by Correlative Multi-Modal Multi-Scale Cryo-Imaging

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Professor William s James

  63. The potential contribution of impaired brain glucose metabolism to congenital Zika syndrome

    Article • Journal of Anatomy, February 2019, Wiley

    Professor Zoltan Molnar, Professor William s James

  64. RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation

    Article • Cell Death and Disease, September 2018, Springer Science + Business Media

    Professor William s James

  65. Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages

    Article • Scientific Reports, August 2017, Nature

    Professor William s James

  66. A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response

    Article • Stem Cell Reports, June 2017, Elsevier

    Professor William s James

  67. LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease

    Article • Biochemical Society Transactions, February 2017, Portland Press Ltd.

    Professor William s James

  68. Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB -Independent Tissue-Resident Macrophages

    Article • Stem Cell Reports, February 2017, Elsevier

    Professor William s James

  69. The nature and nurture of cell heterogeneity: accounting for macrophage gene-environment interactions with single-cell RNA-Seq

    Article • BMC Genomics, January 2017, Springer Science + Business Media

    Professor William s James

  70. Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease

    Article • Nucleic Acids Research, August 2016, Oxford University Press (OUP)

    Professor William s James

  71. A Novel Real Time Imaging Platform to Quantify Macrophage Phagocytosis

    Article • Biochemical Pharmacology, July 2016, Elsevier

    Professor William s James

  72. ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons

    Article • Stem Cell Reports, March 2016, Elsevier

    Professor William s James

  73. CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells

    Article • Experimental Hematology, October 2015, Elsevier

    Professor William s James

  74. Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons

    Article • PLOS One, February 2014, PLOS

    Professor William s James

  75. The Productive Entry Pathway of HIV-1 in Macrophages Is Dependent on Endocytosis through Lipid Rafts Containing CD4

    Article • PLOS One, January 2014, PLOS

    Professor William s James

  76. Differentially expressed, variant U1 snRNAs regulate gene expression in human cells

    Article • Genome Research, October 2012, Cold Spring Harbor Laboratory Press

    Professor William s James

  77. Derivation and Functional Analysis of Patient-Specific Induced Pluripotent Stem Cells as an In Vitro Model of Chronic Granulomatous Disease

    Article • Stem Cells, March 2012, Wiley

    Professor William s James

  78. Several Commercially Available Anti-CCR5 Monoclonal Antibodies Lack Specificity and Should Be Used with Caution

    Article • February 2012, Mary Ann Liebert Inc

    Professor William s James

  79. Transportin 3 Promotes a Nuclear Maturation Step Required for Efficient HIV-1 Integration

    Article • PLoS Pathogens, August 2011, PLOS

    Professor William s James

  80. Protein Kinase C and NF- B-Dependent CD4 Downregulation in Macrophages Induced by T Cell-Derived Soluble Factors: Consequences for HIV-1 Infection

    Article • The Journal of Immunology, June 2011, The American Association of Immunologists

    Professor William s James

  81. Functional human artificial chromosomes are generated and stably maintained in human embryonic stem cells

    Article • Human Molecular Genetics, May 2011, Oxford University Press (OUP)

    Professor William s James

  82. Proteomic-Based Identification of CD4-Interacting Proteins in Human Primary Macrophages

    Article • PLOS One, April 2011, PLOS

    Professor William s James

  83. Generation of neutralizing aptamers against herpes simplex virus type 2: potential components of multivalent microbicides

    Article • Journal of General Virology, April 2011, Society for General Microbiology

    Professor William s James

  84. HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1

    Article • Virology, January 2011, Elsevier

    Professor William s James

  85. Episomal Transgene Expression in Pluripotent Stem Cells

    Article • January 2011, Springer Science + Business Media

    Professor William s James

  86. Protection of HIV Neutralizing Aptamers against Rectal and Vaginal Nucleases: IMPLICATIONS FOR RNA-BASED THERAPEUTICS

    Article • Journal of Biological Chemistry, November 2010, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor William s James

  87. Derivation and characterisation of the human embryonic stem cell line, OxF1

    Article • In Vitro Cellular & Developmental Biology, March 2010, Springer Science + Business Media

    Professor William s James

  88. The roles of apoptotic pathways in the low recovery rate after cryopreservation of dissociated human embryonic stem cells

    Article • Biotechnology Progress, January 2010, Wiley

    Professor William s James

  89. Enhancement of cell recovery for dissociated human embryonic stem cells after cryopreservation

    Article • Biotechnology Progress, December 2009, Wiley

    Professor William s James

  90. The 5′ Leader of the mRNA Encoding the Marek's Disease Virus Serotype 1 pp14 Protein Contains an Intronic Internal Ribosome Entry Site with Allosteric Properties

    Article • Journal of Virology, September 2009, ASM Journals

    Professor William s James

  91. Identification of an Intercistronic Internal Ribosome Entry Site in a Marek's Disease Virus Immediate-Early Gene

    Article • Journal of Virology, March 2009, ASM Journals

    Professor William s James

  92. HIV entry in macrophages is dependent on intact lipid rafts

    Article • Virology, March 2009, Elsevier

    Professor William s James

  93. An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site

    Article • Virology, November 2008, Elsevier

    Professor William s James

  94. Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3

    Article • Experimental Hematology, September 2008, Elsevier

    Professor William s James

  95. Inter-Oligomer Interactions of the Human Prion Protein Are Modulated by the Polymorphism at Codon 129

    Article • Journal of Molecular Biology, August 2008, Elsevier

    Professor William s James

  96. Conformational pH dependence of intermediate states during oligomerization of the human prion protein

    Article • Protein Science, March 2008, Wiley

    Professor William s James

  97. Aptamers in the virologists' toolkit

    Article • Journal of General Virology, February 2007, Society for General Microbiology

    Professor William s James

  98. Oligomerization of the Human Prion Protein Proceeds via a Molten Globule Intermediate

    Article • Journal of Biological Chemistry, December 2006, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor William s James

  99. Molecular Heterosis of Prion Protein β-Oligomers

    Article • Journal of Biological Chemistry, September 2006, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor William s James

  100. An Aptamer That Neutralizes R5 Strains of Human Immunodeficiency Virus Type 1 Blocks gp120-CCR5 Interaction

    Article • Journal of Virology, November 2005, ASM Journals

    Professor William s James

  101. Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1

    Article • RNA, June 2005, Cold Spring Harbor Laboratory Press

    Professor William s James

  102. The presence of valine at residue 129 in human prion protein accelerates amyloid formation

    Article • FEBS Letters, April 2005, Wiley

    Professor William s James

  103. Rapid formation of amyloid from  -monomeric recombinant human PrP in vitro

    Article • Protein Science, March 2005, Wiley

    Professor William s James

  104. Autocatalytic RNA cleavage in the human β-globin pre-mRNA promotes transcription termination

    Article • Nature, November 2004, Nature

    Professor William s James

  105. Assessing potential: the development of selection procedures for the Oxford medical course

    Article • Oxford Review of Education, June 2004, Taylor & Francis

    Professor William s James

  106. Methionine 129 Variant of Human Prion Protein Oligomerizes More Rapidly than the Valine 129 Variant: IMPLICATIONS FOR DISEASE SUSCEPTIBILITY TO CREUTZFELDT-JAKOB DISEASE

    Article • Journal of Biological Chemistry, May 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor William s James

  107. Structural Determinants of Conformationally Selective, Prion-binding Aptamers

    Article • Journal of Biological Chemistry, January 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor William s James

  108. Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2′F-RNA Aptamers

    Article • Journal of Virology, December 2003, ASM Journals

    Professor William s James

  109. Characterization of 2'-Fluoro-RNA Aptamers That Bind Preferentially to Disease-associated Conformations of Prion Protein and Inhibit Conversion

    Article • Journal of Biological Chemistry, August 2003, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor William s James

  110. Molecular epidemiology of dengue virus type 3 in Venezuela

    Article • Journal of General Virology, June 2003, Society for General Microbiology

    Professor William s James

  111. Competing intrachain interactions regulate the formation of beta-sheet fibrils in bovine PrP peptides

    Article • Protein Science, March 2003, Wiley

    Professor William s James

  112. High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands

    Article • Nucleic Acids Research, May 2002, Oxford University Press (OUP)

    Professor William s James

  113. Structural characterization of a 2′F-RNA aptamer that binds a HIV-1 SU glycoprotein, gp120

    Article • Biochemical and Biophysical Research Communications, May 2002, Elsevier

    Professor William s James

  114. Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery

    Article • Current Opinion in Pharmacology, October 2001, Elsevier

    Professor William s James

  115. Neurological manifestations of dengue infection

    Article • The Lancet, March 2000, Elsevier

    Professor William s James

  116. Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes

    Article • Virus Research, April 1999, Elsevier

    Professor William s James

  117. Affinity and Kinetics of the Interaction between Soluble Trimeric OX40 Ligand, a Member of the Tumor Necrosis Factor Superfamily, and Its Receptor OX40 on Activated T Cells

    Article • Journal of Biological Chemistry, February 1997, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor William s James

  118. Comparison of p24 measurement by ELISA versus indicator cells for detecting residual HIV infectivity in vitro

    Article • Journal of Virological Methods, April 1996, Elsevier

    Professor William s James

  119. The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding

    Article • Antiviral Research, March 1996, Elsevier

    Professor William s James

  120. The Receptor for HIV: Dissection of CD4 and Studies on Putative Accessory Factors

    Article • January 1996, Springer Science + Business Media

    Professor William s James

  121. Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site.

    Article • Genes & Development, December 1995, Cold Spring Harbor Laboratory Press

    Professor William s James

  122. RNA enzymes as tools for gene ablation

    Article • Current Opinion in Biotechnology, January 1995, Elsevier

    Professor William s James

  123. Heterokaryons Formed between a Rat Myeloma and a Mouse Fibroblast Are Permissive for Entry of HIV Type 1

    Article • AIDS Research and Human Retroviruses, December 1994, Mary Ann Liebert Inc

    Professor William s James

  124. A rodent cell line permissive for entry and reverse transcription of human immunodeficiency virus type 1 has a pre-integration block to productive infection

    Article • Journal of General Virology, October 1994, Society for General Microbiology

    Professor William s James

  125. Definition of the range and distribution of human immunodeficiency virus macrophage tropism using PCR-based infectivity measurements

    Article • Journal of General Virology, July 1994, Society for General Microbiology

    Professor William s James

  126. HIV-1 pseudotype virus containing a Cocal virus genome and an HIV envelope: construction, assay and use

    Article • Journal of Virological Methods, October 1993, Elsevier

    Professor William s James

  127. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro

    Article • Journal of Experimental Medicine, August 1993, Rockefeller University Press

    Professor William s James

  128. A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection

    Article • Journal of Experimental Medicine, April 1993, Rockefeller University Press

    Professor William s James

  129. Inhibition of HIV-1 replication by ribozymes that show poor activityin vitro

    Article • Nucleic Acids Research, January 1993, Oxford University Press (OUP)

    Professor William s James

  130. Gene Inhibition of HIV-1 Replication.

    Article • Annals of the New York Academy of Sciences, October 1992, Wiley

    Professor William s James

  131. Towards Gene-Inhibition Therapy: A Review of Progress and Prospects in the Field of Antiviral Antisense Nucleic Acids and Ribozymes

    Article • Antiviral Chemistry and Chemotherapy, August 1991, SAGE Publications

    Professor William s James

  132. Development of techniques to analyse the formation of HIV provirus in primary human macrophages

    Article • Research in Virology, January 1991, Elsevier

    Professor William s James

  133. Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA

    Article • Journal of General Virology, September 1990, Society for General Microbiology

    Professor William s James

  134. PCR and the cloning of receptor subtype genes

    Article • Trends in Pharmacological Sciences, September 1989, Elsevier

    Professor William s James

  135. The cytochrome oxidases ofBacillus subtilis: mapping of a gene affecting cytochromeaa3and its replacement by cytochromeoin a mutant strain

    Article • FEMS Microbiology Letters, April 1989, Oxford University Press (OUP)

    Professor William s James

  136. First Workshop of the MRC AIDS-Directed Programme

    Article • Vaccine, June 1988, Elsevier

    Professor William s James

  137. The Head-Tail Linker Protein of Bacteriophage T5: Genetic and Immunological Studies

    Article • Journal of General Virology, April 1987, Society for General Microbiology

    Professor William s James

  138. Host-adaptive Antigenic Variation in Bunyaviruses

    Article • Journal of General Virology, December 1986, Society for General Microbiology

    Professor William s James